Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
| Actual shortage: | 240 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2020-10-30 | 2020-11-12 | 127610 |
| PEMETREXED DISODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Resolved | 2020-10-30 | 2021-01-07 | 127619 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Resolved | 2020-11-06 | 2021-03-18 | 128031 |
| ACT CIPROFLOXACIN | 500MG | TABLET | Resolved | 2021-02-05 | 2023-06-09 | 133460 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2021-02-25 | 2021-04-08 | 134727 |
| TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2021-02-25 | 2021-03-04 | 134733 |
| TEVA-CEFADROXIL | 500MG | CAPSULE | Resolved | 2021-08-05 | 2021-12-02 | 143716 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Resolved | 2021-08-13 | 2021-10-07 | 144105 |
| ACT LEVOFLOXACIN | 500MG | TABLET | Resolved | 2021-08-27 | 2022-01-28 | 144691 |
| TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2021-09-16 | 2022-04-21 | 145786 |
| TEVA-TRYPTOPHAN | 500MG | CAPSULE | Resolved | 2021-09-23 | 2022-05-19 | 146098 |
| TEVA-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2021-10-14 | 2022-02-17 | 147219 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2022-01-20 | 2022-01-28 | 153132 |
| TEVA-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2022-01-20 | 2022-12-02 | 153174 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Resolved | 2022-03-31 | 2022-12-20 | 157650 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Resolved | 2022-04-28 | 2023-01-19 | 159584 |
| ACT LEVOFLOXACIN | 500MG | TABLET | Resolved | 2022-07-25 | 2023-04-28 | 165430 |
| TEVA-CEPHALEXIN | 500MG | CAPSULE | Resolved | 2022-09-07 | 2023-07-28 | 168722 |
| TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2022-09-07 | 2023-04-28 | 168726 |
| TEVA-AMPICILLIN | 500MG | CAPSULE | Resolved | 2022-10-28 | 2022-11-12 | 173034 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
| ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
| HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
| RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
| TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Discontinued | 2020-01-21 | 2020-01-21 | 103788 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |